During development, it is unclear if lineage-fated cells derive from multilineage-primed progenitors and whether active mechanisms operate to restrict cell fate. Here we investigate how mesoderm specifies into blood-fated cells. We document temporally restricted co-expression of blood (Scl/Tal1), cardiac (Mesp1) and paraxial (Tbx6) lineage-affiliated transcription factors in single cells, at the onset of blood specification, supporting the existence of common progenitors. At the same time-restricted stage, absence of SCL results in expansion of cardiac/paraxial cell populations and increased cardiac/paraxial gene expression, suggesting active suppression of alternative fates. Indeed, SCL normally activates expression of co-repressor ETO2 and Polycomb-PRC1 subunits (RYBP, PCGF5) and maintains levels of Polycomb-associated histone marks (H2AK119ub/H3K27me3). Genome-wide analyses reveal ETO2 and RYBP co-occupy most SCL target genes, including cardiac/paraxial loci. Reduction of Eto2 or Rybp expression mimics Scl-null cardiac phenotype. Therefore, SCL-mediated transcriptional repression prevents mis-specification of blood-fated cells, establishing active repression as central to fate determination processes.
Journal article
Nat Commun
18/12/2018
9
Animals, Cell Differentiation, Cell Line, Cell Lineage, Cell Separation, Embryo, Mammalian, Flow Cytometry, Gene Expression Regulation, Developmental, Histone Code, Mesoderm, Mice, Mouse Embryonic Stem Cells, Nuclear Proteins, Polycomb Repressive Complex 1, Polycomb-Group Proteins, RNA, Small Interfering, Repressor Proteins, T-Cell Acute Lymphocytic Leukemia Protein 1, Transcription Factors